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Epstein–Barr virus (EBV) encodes multiple latency programs: a growth-transforming program (type III) latency program and
restricted-latency (types I and II) programs. During type III latency, EBV expresses six nuclear antigens, all of which are
encoded by a single complex transcriptional unit driven by two linked promoters, Cp and Wp, while restricted viral latency
is characterized by the expression of a single nuclear antigen, EBNA1, whose expression is driven from a distinct
transcription unit under the control of the Qp promoter. EBV infection of the 293 epithelial cell line frequently leads to the
establishment of a type I/II latent infection. Here we report that during the initial stages of virus infection of the 293 cell line,
both Cp and Wp are active. However, analysis of four established, low-passage EBV-infected 293 cell lines revealed that three
of these exhibited Qp-driven transcription of the EBNA 1 gene and little or no detectable Cp and Wp activity, while the fourth
cell line exhibited Cp activity. Notably, all four cell lines contained the necessary transcription factors to drive transcription
initiation from Cp and Wp when transiently transfected with unmethylated reporter constructs. Furthermore, in the cell lines
exhibiting restricted EBV latency the viral genomes were extensively methylated around Cp and Wp, but not Qp. In contrast,
in the cell line exhibiting Cp activity the viral genomes were hypomethylated around Cp, Wp, and Qp. Taken together, these
results provide evidence that the establishment of a restricted latent infection in the 293 epithelial cell line is not due to a
failure to initiate the growth-transforming (type III) latency program, but rather may arise from a selection against the typeINTRODUCTION
Epstein–Barr virus (EBV), a DNA tumor virus and mem-
ber of the -herpesvirus family, efficiently transforms
primary B cells and is an etiologic agent of infectious
mononucleosis. In addition, numerous studies have im-
plicated EBV in the development of various human lym-
phoid and epithelial malignancies, including Burkitt’s
lymphoma (BL), nasopharyngeal carcinoma, Hodgkin’s
lymphoma, immunoblastic lymphoma, peripheral T cell
lymphoma, and gastric carcinoma (Rickinson and Kieff,
1996; Imai et al., 1994; Sugiura et al., 1996).
EBV primarily establishes a latent infection in which
the viral genome persists as an episome (Decker et al.,
1996). Several different programs of latency-associated
EBV gene expression have been described. During in-
fectious mononucleosis, in ex vivo infection of B cells,
and in EBV-associated posttransplant lymphoprolifera-
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known as type III latency, which results in B cell growth
transformation (Rickinson and Kieff, 1996). Type III la-
tency is characterized by the expression of a wide array
of viral proteins, including six different EBNAs (Epstein–
Barr nuclear antigens 1, 2, 3a, 3b, 3c, and 4) and three
latency-associated membrane proteins (LMPs 1, 2a, and
2b). Transcription of the EBNAs initiates at one of two
promoters, the C promoter (Cp) or the W promoter (Wp)
(Fig. 1) (Speck and Strominger, 1989). Alternative 3 pro-
cessing and splicing of the long primary transcripts re-
sults in the production of the mature transcripts encod-
ing the EBNAs (Fig. 1). Upon ex vivo infection of B cells,
EBNA gene transcription initially arises from the proximal
EBNA gene promoter Wp, followed by induction of EBNA
gene transcription from the distal EBNA gene promoter
Cp (Woisetschlaeger et al., 1990). EBNA 1 upregulates
transcription from Cp and Wp by binding to oriP, the
latency-associated origin of replication located upstream
of Cp (Puglielli et al., 1996) (Fig. 1), which also functions
to maintain the viral episome (Aiyar et al., 1998). EBNA 2,
which acts through a direct interaction with the cellularIII latency program. Furthermore, these results are consist
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upstream of Cp (Sung et al., 1991; Jin and Speck, 1992;
Henkel et al., 1994) (Fig. 1). The EBNA 3 family also
interacts with CBF1/RBP-J and serves to negatively reg-
ulate EBNA gene transcription initiation from Cp (Fig. 1).
Thus, EBNA gene transcription during type III latency is
autoregulated by the EBNA gene products.
In healthy seropositive individuals and in most EBV-
positive tumors, EBV establishes a restricted form of
latency characterized by extremely limited viral gene
expression. During restricted latency, only one of the six
EBNAs, EBNA 1, is expressed, and transcription of the
EBNA1 gene during restricted viral latency arises from a
distinct promoter, Qp (Schaefer et al., 1995; Nonkwelo et
al., 1996) (Fig. 1), while Cp and Wp are transcriptionally
inactive. In healthy seropositive individuals, EBV persists
in the memory B cell compartment (sIg-positive, sIgD-
negative, CD23-negative, B7-negative) (Babcock et al.,
1998), where it expresses only LMP2A or LMP2A plus
Qp-driven EBNA 1 (Babcock et al., 1998; Tierney et al.,
1994; Qu and Rowe, 1992; Chen et al., 1995). Little or no
transcription has been detected from Cp, and no Wp-
initiated transcripts have been observed in the long-term
latency reservoir (Tierney et al., 1994; Qu and Rowe,
1992; Chen et al., 1995). Similarly, in many EBV-positive
tumors and in cell lines derived from these tumors, Qp-
initiated EBNA 1 transcripts are observed, either alone
(type I latency, observed in Burkitt’s lymphoma), or in
combination with the LMPs (type II latency, seen in
Hodgkin’s lymphoma and nasopharyngeal carcinoma)
(Rickinson and Kieff, 1996; Tao et al., 1998a). EBNA 1, in
contrast with its role as a positive regulator of Cp/Wp
activity, functions to negatively regulate Qp, by binding
to two low-affinity repressor sites located downstream
of Qp (Sample et al., 1992) (Fig. 1). Since EBNA 1 fails
to undergo presentation to CD8 T cells, whereas all
of the other EBNAs elicit a strong CD8 T cell re-
sponse, restricted latency likely facilitates immune eva-
sion (Levitskaya et al., 1995).
FIG. 1. (A) Diagram showing the locations of the Cp, Wp, and Qp promoters in the EBV genome and illustrating the Epstein–Barr Nuclear Antigen
(EBNA) transcript structures observed during type III latency and restricted (type I/II) latency (Rickinson and Kieff, 1996; Speck and Strominger, 1989).
Type III latency involves expression of all six EBNAs, generated by alternative splicing of long primary transcripts that initiate at either Cp or Wp.
During restricted latency, only one of the EBNAs, EBNA 1, is expressed; it is transcribed from Qp rather than from Cp or Wp. Fp is a lytic cycle promoter
located upstream of Qp. OriP is the latency-associated origin of episomal replication. IR1 is the major internal repeat, which consists of variable
numbers of the 3-kb W region. (B) Illustration of the elements involved in the transcriptional regulation of Cp, Wp, and Qp. EBNA 1 binding to oriP
functions to upregulate Cp and Wp activity, as well as to assist with episomal replication. I  glucocorticoid response element (Kupfer and Summers,
1990); II  EBNA-2-responsive element that enhances Cp activity (Sung et al., 1991; Jin and Speck, 1992; Henkel et al., 1994); III  shared Cp/Wp
enhancer (Nilsson et al., 1993; Ricksten et al., 1988; Walls and Perricaudet, 1991); and IV  Interferon Regulatory Factor (IRF) element required for
Qp transcription (Schaefer et al., 1997; Nonkwelo et al., 1997). EBNA 1 also functions to downregulate Qp by binding to two low-affinity sites
downstream of Qp (Sample et al., 1992).
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Previous studies have demonstrated that EBNA 1 ac-
tivates transcription from Cp or Wp and represses Qp
(Fig. 1), indicating that type III latency should be the
default latency program (Schaefer et al., 1997). Further-
more, transient transfection of Cp and Wp-driven reporter
constructs into EBV-infected cell lines exhibiting re-
stricted viral latency demonstrated that, while the endog-
enous Cp and Wp promoters remain silent, the trans-
fected Cp and Wp promoters were active. The latter
observation provided evidence that during restricted la-
tency the required transcription factors to drive Cp and
Wp are present (Schaefer et al., 1995, 1997; Jansson et
al., 1992; Robertson et al., 1995). Furthermore, numerous
analyses of EBV-positive tumor cell lines have demon-
strated a consistent correlation between restricted EBV
latency and methylation of Cp and Wp (Ernberg et al.,
1989; Masucci et al., 1989; Altiok et al., 1992; Jansson et
al., 1992; Minarovits et al., 1991, 1994; Robertson et al.,
1995, 1996; Schaefer et al., 1997; Tao et al., 1998a; Allday
et al., 1990).
Here we characterize a tissue culture EBV infection
model that frequently leads to the establishment of type
I/II latency. These analyses reveal that, during the initial
stages of EBV infection of the 293 epithelial cell line, both
Cp and Wp are active. However, subsequent analyses of
EBV-infected 293 cell lines demonstrated that in three of
four cell lines analyzed both Cp and Wp were inactive
and heavily methylated, while Qp was hypomethylated.
Thus, EBV infection of the 293 epithelial cell lines pro-
vides an experimental system to assess the establish-
ment of restricted viral latency and the role of viral ge-
nome methylation in this process.
RESULTS
Cp and Wp are active at early times postinfection of
293 epithelial cells
It has previously been shown that EBV infection of the
293 epithelial cell line predominantly results in the es-
tablishment of type II latency (Fingeroth et al., 1999). To
assess whether failure to establish type III latency re-
flects a block in Cp and/or Wp-initiated EBNA gene
transcription during the establishment of latency, we
monitored EBNA gene transcription during the early
stages of EBV infection of the 293 cell line (Fig. 2). Since
it has been demonstrated that EBV uses HLA class II as
a cofactor for infecting B cells (Li et al., 1997), to increase
the efficiency of EBV infection of the 293 epithelial cell
line we used the 293/pZCIITA.2 cell line in which HLA
class II expression was induced by stable introduction of
a vector driving expression of the cellular transcription
factor CIITA (J. Fingeroth, unpublished data). As a posi-
tive control, we also assessed EBNA gene promoter
activity in peripheral blood lymphocytes (PBL) at various
times postinfection (Fig. 2).
Wp-initiated transcripts were readily detected by 1 day
postinfection of PBL and were also weakly detectable in
infected 293/pZCIITA.2 cells (Fig. 2). Cp-initiated tran-
scripts were also detected by 1 day postinfection in
infected 293/pZCIITA.2 cells, but not in infected PBL. It
should be noted that the multiple amplification products
observed with the Cp (C1/W2 exon primers) and Wp
(W0W1/W2 exon primers) RT-PCR reactions arises from
hybridization of the downstream W2 primer to multiple
primer binding sites within the EBNA gene transcripts
(see schematic illustration of anticipated amplification
products shown in Fig. 2). By 2 days postinfection Cp-
initiated transcripts were readily detectable in both in-
fected 293/pZCIITA.2 and PBL, which increased by day 3
postinfection and remained relatively constant through
day 10 postinfection. Notably, Wp-initiated transcripts
were also readily detectable over 10 days postinfection
in PBL, but were not detected at day 6 or later in infected
293/pZCIITA.2 cells. In addition, at late times postinfec-
tion (days 14 and 17) the level of Cp-initiated transcripts
in infected 293/pZCIITA.2 cells appeared to decrease. In
contrast to readily detectable levels of Cp- and Wp-
initiated transcripts, little or no Qp-initiated transcripts
were detected in either infected 293/pZCIITA.2 or PBL at
anytime postinfection. Although the RT-PCR assays used
were not designed to be quantitative, the assays were
optimized to detect significant differences in the levels of
Cp-, Wp-, and Qp-initiated transcripts present in estab-
lished cell lines (Schlager et al., 1996).
Three low-passage EBV-infected 293 epithelial cell
lines utilize Qp, while a fourth cell line exhibits both
Cp activity and spontaneous lytic activity
EBV-positive epithelial cell lines were generated by
infecting the 293 epithelial cell line with recombinant
EBV harboring a neomycin-resistance expression cas-
sette, as previously described (Fingeroth et al., 1999).
The four established EBV-infected 293 epithelial cell
lines (293-2, 293-7, 293-5, and 293-6) were minimally
passaged prior to analysis of EBNA gene promoter us-
age and viral genome methylation. To assess EBNA
gene promoter usage in the four cell clones, RNA was
isolated from each cell line followed by S1 nuclease
protection analyses and RT-PCR to detect transcripts
arising from Cp, Wp, and Qp. Specific protection of the
Cp S1 probe was observed with RNA isolated from the
293-7 cell line, as well as in the Cp-positive control
lymphoblastoid cell line (LCL) JY, whereas the 293-2, -5,
and -6 cell lines exhibited no detectable Cp activity (Fig.
3A). In contrast, none of the epithelial cell lines exhibited
Wp activity, although specific protection of the Wp probe
was readily detected with RNA isolated from the positive
control clone-16 BL cell line (Fig. 3B). It should be noted
that the total protection of the Wp probe observed with
RNA from the 293-7 cell line is thought to reflect partially
spliced EBNA gene transcripts arising from Cp and is
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consistently detected in cell lines exhibiting Cp activity
(Woisetschlaeger et al., 1989, 1990, 1991). S1 nuclease
protection assays for the abundant housekeeping gene
-actin served as a loading control and confirmed that
intact RNA was isolated from all the cell lines assayed
(Figs. 3A and 3B, lower panels).
To further assess EBNA gene promoter usage, re-
verse-transcriptase PCR (RT-PCR) analysis of Cp-, Wp-,
and Qp-initiated transcripts was carried out. This analy-
sis revealed the presence of weak amplification of Cp-
initiated transcripts in the 293-5 and 293-6 cell lines (Fig.
4). Weak Cp activity was also occasionally detected in
the 293-2 cell clone as well (data not shown). However,
this low-level Cp activity was not detectable by the quan-
titative, but less sensitive, S1 nuclease analyses (see
Fig. 3). Consistent with the S1 nuclease protection anal-
yses, strong RT-PCR amplification of Cp-initiated tran-
scripts was observed with RNA isolated from the 293-7
and positive control cell lines (Fig. 4). No Wp-initiated
transcripts were detected by RT-PCR amplification of
cDNA from the 293-2, 293-5, and 293-6 cell clones (Fig.
4). The 293-7 cell clone, on the other hand, exhibited a
low level of Wp-initiated transcripts (Fig. 4) that were
undetectable by S1 nuclease protection (Fig. 3B). RT-PCR
analyses of five independent RNA isolations from these
cell lines gave the same results (data shown in Fig. 4 is
from one representative experiment). In addition, to de-
termine whether any of the observed Cp-initiated tran-
scripts were functional EBNA gene transcripts, we car-
ried out RT-PCR with primers that are diagnostic for Cp-
or Wp-initiated EBNA1 transcripts. This analysis utilized
a 5 primer in the Y3 exon (located downstream of the
BamHI W repeats) and a 3 primer in the K (EBNA1) exon.
This RT-PCR assay demonstrated the presence of appro-
priately spliced EBNA1 transcripts in the 293-7 cell line,
whereas no transcripts containing the Y3 and K exons
were detected with RNA isolated from the 293-2, 293-5,
and 293-6 cell lines (data not shown).
RT-PCR analyses were also performed to examine
Qp-initiated EBNA 1 transcripts, using a 5 primer in the
Q exon and a 3 primer in the EBNA 1 coding exon (K
exon). The RT-PCR revealed readily detectable Qp-driven
FIG. 2. EBV infection of 293 cells leads to detectable Wp and Cp activity at early times postinfection. A 293 cell line in which HLA class II expression
was induced by stable introduction of a vector driving expression of the cellular transcription factor CIITA (293/pZCIITA.2; J. Fingeroth, unpublished
data) was either mock-infected or infected with the B95.8 strain of EBV. EBV infection of human PBL served as a positive control. RNA was isolated
at the indicated times postinfection and RT-PCR performed to examine EBNA gene promoter activity. Pos cntl  RNA isolated from a positive control
cell line. The Wp using Burkitt’s lymphoma cells clone-16 served as a positive control for Wp activity, while RNA isolated from the JY lymphoblastoid
cell line served as a positive control for Cp activity. RNA prepared from the 293-2 cell line, described here to exhibit restricted EBV latency, was
employed as a positive control for Qp-initiated transcription.
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EBNA 1 transcripts in the 293-2, -5, and -6 cell lines (Fig.
4). Thus, the 293-2, 293-5, and 293-6 cell lines exhibit
little or no transcription from Cp and Wp, but significant
levels of Qp-initiated transcripts, consistent with estab-
lishment of a restricted latent infection. A low level of
Qp-initiated transcripts could also be detected in the
293-7 cell line (Fig. 4). The latter may indicate the pres-
ence of a subpopulation of 293-7 cells that exhibit a
restricted latency phenotype or, alternatively, may reflect
low-level Qp-driven EBNA1 gene transcription in the
presence of Cp-driven EBNA gene transcription (i.e., per-
haps EBNA1 levels are not sufficient to completely inhibit
Qp activity).
Since spontaneous lytic activity has been observed in
some EBV-infected epithelial cells in culture (Knox et al.,
1996; Yoshiyama et al., 1997), we assessed spontaneous
virus replication by determining the presence of BHLF1
transcripts (the most abundant early lytic transcript).
BHLF1 transcripts were only detectable in the 293-7 cell
line (Fig. 3C). RNA prepared from the clone-16 type III
latent cell line treated with the lytic cycle inducers TPA
and ionomycin served as a positive control (Fig. 3C). The
absence of detectable spontaneous virus replication in
the EBV-positive 293-2, 293-5, and 293-6 cell lines, which
exhibit restricted viral latency, makes possible a detailed
analysis of viral genome methylation in these cell lines
(i.e., during virus replication the reactivating cells contain
a large number of rapidly dividing viral genomes, which
are unmethylated and thus could confound analyses of
the methylation status of the viral genome during latent
infection).
The 293-2, 293-5, and 293-6 epithelial lines contain the
necessary transcription factors to activate Cp and Wp
The lack of Cp and Wp activity in the 293-2, 293-5, and
293-6 cell lines may result either from the presence of a
transcriptional repressor or from the absence of an es-
sential transcription factor(s). Alternatively, silencing of
Cp and Wp may occur through another means, such as
methylation of the viral genome. To determine whether
the EBV-infected 293 cell lines are capable of initiating
transcription from Cp, we transiently transfected these
cell lines with either a tagged Cp-driven reporter con-
struct (CtagWtagW1 -globin) (Puglielli et al., 1997) or an
irrelevant reporter construct. The Cp-driven reporter
plasmid contained extensive surrounding genomic se-
quence, including an entire copy of the BamHI W repeat
(and a portion of a second copy), as well as oriP, the
latency-associated origin of replication that functions as
an EBNA1-dependent enhancer of Cp and Wp activity
(Puglielli et al., 1996, 1997). The introduction of a se-
quence tag in the first exon, C1, allowed transcripts
arising from the transiently transfected reporter construct
to be distinguished from transcripts arising from the
endogenous viral genome(s). All epithelial cell lines dis-
FIG. 3. Analysis of EBNA promoter usage and lytic gene expression in four low-passage EBV-infected epithelial cell clones. (A) S1 nuclease
protection analysis of Cp activity in the epithelial cell clones. RNA was isolated from the four epithelial cell clones, hybridized with a 32P-labeled Cp
or -actin probe, and digested with S1 nuclease. RNA from the Cp-positive type III latent cell line JY served as a positive control for Cp activity,
whereas RNA from the type I latent Burkitt’s lymphoma cell line Rael was included as a negative control for Cp activity. (B) S1 nuclease protection
analysis of Wp activity in the epithelial cell clones. RNA was isolated from the four epithelial cell clones, hybridized with a 32P-labeled Wp or -actin
probe, and digested with S1 nuclease. The Wp-positive type III latent cell line Clone 16 was utilized as a positive control for Wp activity. 293 is the
parental EBV-negative cell line. 293 is the parental EBV-negative cell line.
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played Cp-initiated transcription from the transiently
transfected, unmethylated Cp reporter plasmid, whereas
no protection was observed in cells transfected with the
irrelevant negative control construct (Fig. 5, upper left-
hand panel). In addition, no detectable Cp-initiated tran-
scripts were detected from the endogenous viral ge-
nome in any of the EBV-infected 293 cell lines, with the
exception of the 293-7 cell line, which was previously
shown to exhibit Cp activity (Fig. 5, lower left-hand panel).
The latter result demonstrated that transient transfection
of the 293 cell lines does not upregulate Cp activity from
the endogenous viral genome.
A parallel analysis was carried out to determine the
ability of the 293 cell lines to utilize Wp. To assess Wp
activity, a reporter construct was used that was previ-
ously shown to display Wp activity in type III latently
infected cells (CinvWtagW1 -globin) (Puglielli et al.,
1997). All epithelial cell lines transiently transfected with
this Wp reporter construct exhibited Wp(tag) activity, as
assessed by S1 nuclease analysis (Fig. 5, upper right-
hand panel), whereas the endogenous Wp remained
silent (Fig. 4, lower right-hand panel). Taken together,
these results indicate that the 293 epithelial cell lines
possess the necessary factors to transcribe from both
Cp and Wp and thus argues against the presence of a
Cp/Wp transcriptional repressor in the 293-2, 293-5, and
293-6 cell lines.
Cp and Wp are methylated, while Qp is unmethylated,
in the EBV-infected epithelial cell lines that exhibit
restricted viral latency
To examine the methylation pattern around the EBNA
gene promoters, we utilized bisulfite-PCR analysis,
which allows the methylation status of every CpG in a
particular region to be examined. Bisulfite-PCR involves
treating genomic DNA with sodium metabisulfite, which
converts unmethylated cytosines into uracils (read as
thymine by Taq polymerase), but fails to react with meth-
ylated cytosines (Clark et al., 1994; McDonald and Kay,
1997; Raizis et al., 1995). PCR was performed using
primers that were specifically designed to amplify bisul-
fite-modified DNA and the resulting PCR products were
cloned and sequenced. As a control for the efficiency of
the bisulfite reaction, we confirmed that all non-CpG
cytosines were converted into thymines. In addition, for
FIG. 4. RT-PCR analysis of EBNA gene transcription. RT-PCR assays for Cp-, Wp-, and Qp-initiated transcripts in the EBV-positive 293 epithelial cell
clones. RNA isolated from the Cp-positive cell line JY served as a positive control for Cp activity, and Clone 16 was used as a Wp-positive control.
RNA from the type I BL cell line Rael was included as a positive control for Qp activity. 293 is the parental EBV-negative cell line. All primers cross
splice junctions (primer locations and cDNA synthesis/PCR conditions are described under Materials and Methods). The data shown is one
representative experiment of five independent rounds of RNA isolation, cDNA preparation, and RT-PCR amplification.
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each cell line, we analyzed at least five independently
generated bisulfite PCR products, derived from two in-
dependent genomic DNA preparations and multiple
bisulfite reactions.
Bisulfite PCR analysis of the region surrounding Cp
revealed a moderate to high level of methylation in the
three Qp-positive cell lines, 293-2, 293-5, and 293-6 (Fig.
6A). For 293-2, 35 to 65% of the CpGs in the analyzed
region of Cp were methylated (average  54%). Methyl-
ation was also observed at 65 to 95% of the CpGs in the
293-5 cell line (average 84%) and from 20 to 95% of the
CpGs in the 293-6 cell line (average 71%). Interestingly,
we recently examined methylation around Cp in the long-
latency reservoir in healthy seropositive individuals and
found that Cp was methylated to a similar or lesser
extent in these individuals than in the 293-2 cell line
(Paulson and Speck, 1999). In the 293-5 and 293-6 cell
lines the region around Cp was on average more
densely methylated than in the 293-2 cell line. In con-
trast, in the 293-7 cell line, which contains both Cp-
initiated transcripts and spontaneous lytic activity, the
viral genome was hypomethylated around Cp (Fig. 6A).
The latter is consistent with previous observations in
type III lymphoblastoid cell lines (Minarovits et al., 1991;
Schaefer et al., 1997).
The region around Wp was densely methylated in all
three Qp-using epithelial cell lines (293-2, 293-5, and
293-6) (Fig. 6B). In vitro studies have shown that methyl-
ation of Wp reporter constructs inhibits transcription from
Wp (Jansson et al., 1992), suggesting that the methylation
observed around Wp in these three epithelial cell clones
would be expected to repress transcription initiation
from Wp. In contrast, the viral genomes present in the
293-7 cell line were unmethylated around Wp in five of
six independently generated PCR clones and lightly
methylated in the remaining bisulfite-PCR clone analyzed
(Fig. 6B). These results extend the correlation between
methylation of Cp and Wp and the establishment of
restricted latency (Jansson et al., 1992; Minarovits et al.,
1991).
We also examined the methylation status of Qp, as
well as the upstream lytic cycle-associated promoter Fp.
Other studies have found that Qp lacks methylation in
cells that exhibit either restricted latency or type III la-
FIG. 5. EBV-infected 293 cell lines possess the necessary factors to drive Cp- and Wp-initiated transcription from transiently transfected,
unmethylated reporter constructs. The 293-2, 293-7, 293-5, and 293-6 cell clones, as well as the parental 293 cells, were transiently transfected with
a Cp-driven reporter construct (Puglielli et al., 1997) containing sequence tags within the C1 and W0 exons, to allow distinction between
plasmid-derived transcripts and endogenous viral transcripts. As a negative control, cells were transfected with an irrelevant CAT construct. RNA was
isolated at 48 h posttransfection and analyzed in S1 nuclease protection assays for tagged Cp, -actin, and endogenous Cp. (A) S1 assay done with
either a Cp-tag probe (Cp*), to look for Cp-initiated transcription from the transfected construct, or a -actin probe. cntl  negative control irrelevant
construct. (B) S1 assay employing a probe to detect endogenous Cp-initiated transcripts performed on RNA from cells transfected with the tagged
Cp reporter construct. (C) S1 assay with either a Wp-tag probe (Wp*), to assess the presence of transcripts initiating from the transfected Wp construct,
or a -actin probe. cntl  negative control irrelevant construct. (D) S1 nuclease protection analysis employing a probe to detect Wp-initiated
transcripts arising from the endogenous viral genome, performed on RNA isolated from cells transfected with the tagged Wp reporter construct.
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tency (Schaefer et al., 1997; Tao et al., 1998b). Also, we
recently demonstrated that Qp remains unmethylated in
the peripheral B cells of healthy EBV-seropositive donors
(Paulson and Speck, 1999). In accordance with these
studies, the region immediately surrounding Qp was
unmethylated in the 293-2, 293-5, and 293-6 cell lines,
and also in all but one of the viral genomes analyzed
from the 293-7 cell line (Fig. 6C). These results imply that
Qp is either protected from methylation or targeted for
demethylation. The region surrounding Fp, on the other
hand, was lightly methylated in several of the viral ge-
nomes analyzed from the EBV-infected 293 cell lines (Fig.
6C). However, a correlation between absence of methyl-
ation and promoter activity does not necessarily hold
true for lytic cycle-associated promoters. For instance, in
type III lymphoblastoid cell lines, lytic cycle associated
promoters are largely unmethylated yet inactive (Minaro-
vits et al., 1991). This finding implies that methylation is
not required to keep a lytic promoter off, but a methylated
lytic cycle-associated promoter probably requires de-
methylation to become active. Demethylation of DNA
prior to lytic cycle entry has been observed (Szyf et al.,
1985). The significance of the one 293-7 clone that ex-
hibits hypermethylation around both Qp and Fp is un-
known.
DISCUSSION
We have shown that low-passage EBV-infected epithe-
lial cell lines, 293-2, 293-5, and 293-6, exhibit restricted
latency (as defined by transcription of EBNA 1 from Qp,
and lack of Cp and Wp activity) and display extensive
methylation around Cp and Wp. These results demon-
strate that methylation of Cp and Wp is not limited to
EBV-associated tumors and cells that have undergone
long-term passage in tissue culture. In addition, these
findings further strengthen the correlation between
methylation of Cp and Wp, inactivity of these promoters,
and establishment of a restricted latency program. Im-
portantly, the robust appearance of Cp- and Wp-initiated
transcripts during the early phases of EBV infection of
For each 293 cell clone, at least five independently generated bisulfite
PCRs were analyzed (seven PCRs from 293-2, five PCRs from 293-5, six
PCRs from 293-6, and five PCRs from 293-7 were sequenced). The
locations of the Cp/Wp enhancer, the CCAAT box, the Wp TATAA box
and transcription start site, and the W0 exon are indicated. (B) Meth-
ylation pattern in the region upstream of Cp. At least five independently
generated PCRs were sequenced per 293 cell clone. Also shown are
the locations of the EBNA 2 enhancer, the CCAAT boxes, and the Cp
TATAA box and transcription start site. The P in 293-5 PCR 3 represents
a polymorphism (CpG to TpG mutation). (C) Methylation around Qp, the
EBNA 1 promoter during restricted latency, and Fp, a lytic cycle pro-
moter. At least five independently generated PCRs were analyzed for
each 293 cell clone. The locations of the Fp TATAA box and transcrip-
tion start site, the IRF1/2 binding site, the Qp transcription start site, and
the low-affinity EBNA 1 binding sites are also indicated.
FIG. 6. Methylation of Cp and Wp correlates with establishment of
restricted EBV latency in EBV-infected 293 cells. Genomic DNA was
isolated from the epithelial clones and from the EBV-negative Burkitt’s
lymphoma cell line DG75. DNA was bisulfite-treated, amplified by
bisulfite PCR, cloned, and sequenced. The genome coordinates of the
CpGs in the amplified regions are listed on the left side of each panel.
  unmethylated CpGs, and ●  methylated CpGs. Each numbered
column shows the data obtained from an independent bisulfite PCR
amplification. (A) Analysis of methylation in the region upstream of Wp.
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the 293 cell line argues that establishment of a restricted
latency program in the 293 epithelial cell line did not
reflect a failure of the type III latency program to function
in these cells.
We did not uncover any evidence for a lack of an
essential Cp/Wp transcription factor(s) or for the pres-
ence of a Cp/Wp transcriptional repressor in 293 cells.
Transiently transfected, unmethylated Cp and Wp re-
porter constructs displayed activity in all of the EBV-
infected 293 cell lines, as well as in the parental 293
EBV-negative cells (Fig. 5). Furthermore, as discussed
above, we have demonstrated that Cp and Wp are active
during the initial stages of EBV infection of the 293 cell
line (Fig. 2). Taken together, these data are consistent
with DNA methylation of Cp and Wp as being a primary
mechanism of suppressing the type III latency program.
One important question is whether the methylation
observed around Cp and Wp in the 293-2, 293-5, and
293-6 cell lines is sufficient to repress transcription from
these promoters. In vitro methylation of Cp and Wp re-
porter constructs inactivates these promoters (Robertson
and Ambinder, 1997; Jansson et al., 1992). Also, in vitro
methylation studies have shown that as little as 7%
methylation of a reporter construct can lead to a 60–90%
reduction in transcription, and higher levels of methyl-
ation almost completely abolish transcription, even in the
presence of a strong transcriptional enhancer (Boyes
and Bird, 1992; Hsieh, 1994; Kass et al., 1997). These
findings suggest that the extensive methylation observed
around Wp in the 293-2, 293-5, and 293-6 cell clones
should be sufficient to repress Wp-initiated transcription,
and the moderate to high level of methylation around Cp
probably suffices to inhibit transcription from Cp as well.
The low level of Cp activity that was sporadically ob-
served in the Qp-positive epithelial cell lines might rep-
resent transcription from genomes with a lower level of
methylation around Cp, such as the methylation pattern
observed in the 293-6 Cp bisulfite-PCR 4 (Fig. 6).
One intriguing possibility is that methylation around
Wp may repress transcription from Cp as well as from
Wp. A lower level of methylation around Cp, such as that
observed in 293-6 bisulfite PCR 4 (Fig. 6), may not be
enough to significantly inhibit transcription from Cp.
However, all of the analyzed Wp bisulfite-PCR analyses
revealed extensive methylation; the heavy methylation
around Wp could contribute to repression of transcription
from Cp as well as Wp. In support of this idea, we
recently demonstrated that methylation of sequences
around Wp in a Cp-driven reporter construct strongly
inhibited Cp-driven reporter gene expression (Paulson
and Speck, 1999). This may reflect inhibition of transcrip-
tion elongation through the W repeat region and/or by
inhibition of the function of the shared Cp/Wp enhancer
located just upstream of Wp.
The absence of methylation around Qp in all four
epithelial cell lines implies that unknown factors, such as
binding of specific proteins, may either prevent methyl-
ation of Qp or target Qp for demethylation. EBNA 1,
required for episomal maintenance, is the only viral pro-
tein that is absolutely essential for EBV survival. Since
the only known way to produce EBNA 1 is from tran-
scripts that originate at Cp, Wp, or Qp, protection of Qp
from methylation may ensure that Qp can function as a
default promoter to generate EBNA 1 under circum-
stances when Cp and Wp are inactive. Currently, little is
known about elements that protect a promoter from
methylation (or target it for demethylation). SP1 family
members appear to prevent methylation of the cellular
APRT gene (Brandeis et al., 1994; Macleod et al., 1994),
and transcription factor binding is a prerequisite for de-
methylation in Xenopus embryos (Matsuo et al., 1998). In
addition, demethylation of an in vitro methylated stably
transfected oriP plasmid appears to depend upon EBNA
1 (Hsieh, 1999).
In summary, 293 is an example of a cell line that can
be infected in vitro with EBV and used to generate cell
lines that display restricted latency. By every measure so
far, including Cp/Wp methylation, Qp activity, absence of
methylation around Qp, lack of Cp/Wp activity, and ex-
pression of EBNA 1 but not EBNA 2 (Fingeroth et al.,
1999), three of the four epithelial cell clones mimic the
restricted latency programs that have been observed in
vivo, in freshly isolated EBV-positive tumors (Robertson
et al., 1996; Tao et al., 1998a) as well as in healthy
seropositive individuals (Babcock et al., 1998; Tierney et
al., 1994; Qu and Rowe, 1992; Chen et al., 1995; Paulson
and Speck, 1999). Based on these findings, the 293 cell
line provides a tractable experimental system to assess
the role of methylation in the establishment and mainte-
nance of restricted EBV latency, as well as to determine




The 293 cell line (available from ATCC) was originally
established by transforming human embryonic kidney
epithelium with adenovirus DNA (Graham et al., 1977).
The 293-2 and 293-7 cell lines were generated by infec-
tion of 293 cells with B-652 EBV, a recombinant B95.8
(wild-type sequenced laboratory strain of EBV) virus con-
taining the CMVIE-neo gene (driven by the cytomegalo-
virus immediate-early promoter) downstream of the
EBNA 1 coding exon (shown not to affect any known
genes), as previously described (Fingeroth et al., 1999).
The 293-5 and 293-6 cell lines were established by
infecting 293 cells with P3-531 EBV, which contains the
CMVIE-neo gene in place of the nonessential BHRF1
open reading frame (Fingeroth et al., 1999). G418-resis-
tant EBV-infected cell lines were selected by growth in
G418-containing media, as described previously (Fin-
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geroth et al., 1999). Uninfected 293 cells were cultured in
Iscove’s modified Dulbecco’s medium with 10% fetal calf
serum, glutamine, and penicillin/streptomycin. The EBV-
infected 293 cell lines were grown in the same media
supplemented with 700 g/ml active G418. All epithelial
cell lines were minimally passaged prior to carrying out
the analyses described here (once established, the
293-2 and 293-7 cell lines were passaged twice a week
for 2 to 3 weeks, while the 293-5 and 293-6 cell lines
were passaged twice a week for about 6 weeks). The
293/pZCIITA.2 cell line was generated by stable introduc-
tion into the 293 epithelial cell line of a vector (pZeoSV,
Invitrogen) driving expression of the MHC Class II trans-
activator (CIITA), resulting in high-level surface expres-
sion of HLA DR. The generation and characterization of
the 293/pZCIITA.2 cell line will be described elsewhere
(J. Fingeroth, unpublished data). 293/pZCIITA.2 cells
were grown in DMEM supplemented with 10% fetal calf
serum, penicillin/streptomycin, and 500 g/ml Zeocin
(Invitrogen).
RNA isolation and S1 nuclease protection assays
RNA was isolated from the 293 cells and EBV-infected
cell clones by the GITC-phenol method (Chomczynski
and Sacchi, 1987). RNA (15 g from the transfected cells
and 30 g from the untransfected cells) was hybridized
overnight at 42°C with the appropriate 32P-labeled S1
probe, digested with S1 nuclease, and analyzed on a 10%
polyacrylamide/7 M urea gel as described previously
(Puglielli et al., 1996, 1997; Woisetschlaeger et al., 1990).
The S1 oligos have been described previously: C1 (Woi-
setschlaeger et al., 1989) and W0W1 (Woisetschlaeger et
al., 1990) (both used to detect transcription from the
endogenous viral genome), Cp (tagged) and Wp (tagged)
(Puglielli et al., 1997) (both used to detect transcription
from the transfected tagged constructs), and -actin
(Puglielli et al., 1997).
Transfections and plasmids
The epithelial cell lines were transfected by the CaPO4
method, using a kit made by Invitrogen (Carlsbad, CA).
The day before transfection, 106 cells were plated in
100-mm tissue culture dishes. Three hours prior to trans-
fection, the media was removed and replaced with fresh
media. The cells were transfected according to the In-
vitrogen protocol, with 5 g of a plasmid that exhibits Cp
activity (oriPCWW1 Gt) (Puglielli et al., 1997), a plasmid
that exhibits Wp activity (oriPCinvCATWW1 Gt) (Puglielli
et al., 1997), or an irrelevant reporter construct. RNA was
isolated at 48 h posttransfection by the GITC-phenol
method (Chomczynski and Sacchi, 1987). The EBV plas-
mids contain oriP, Cp, and the first two copies of Wp (EBV
genome coordinates 7315 to 17,633), linked to the -glo-
bin reporter gene. (The oriPCpinvCATWW1 Gt construct
contains Cp in an inverted orientation relative to Wp and
was previously shown to have Wp activity in lymphoblas-
toid cell lines (Puglielli et al., 1997)).
cDNA synthesis and RT-PCR
Total RNA was isolated as described above. cDNA
was synthesized from 3 g of total RNA with Superscript
II reverse transcriptase, oligo(dT), and random primers
(all from Gibco-BRL), as specified in the Gibco-BRL pro-
tocol. Two microliters of the 20 l cDNA reaction was
PCR-amplified in a 50 l reaction with 350 ng of each
primer; the MgCl2 concentration was 1.5 mM. All primers
cross splice junctions, and the sequences are as follows:
Cp RT-PCR: C1 (genome coordinate 11,342), 5-TGTA-
GATCTGATGGCATAGAGAC; W2 (genome coordinate
14,735), 5-ACTGAAGCTTGACCGGTGCCTTCTTAGGAG.
Wp RT-PCR: W0W1B (genome coordinate 14,396), 5-
GGAGTCCACACAAATCCT; W0W1B (for alternative
splice site), 5-GGAGTCCACACAAATGGG; W2B (genome
coordinate 14,735), 5-ACCGGTGCCTTCTTAGGA-G. Both
Cp and Wp primer sets were described in an earlier
article (Schlager et al., 1996). Qp RT-PCR: Q3B (genome
coordinate 62,437), 5-AGCGTGCGCTACCGGAT; K2 (ge-
nome coordinate 107,964), 5-CCCCTCGTCAGACATGAT.
The amplification conditions utilized for all primer pairs
were 35 cycles of 94o 1 min, 63o 1 min, and 72o 1.5 min.
EBV infection of peripheral blood lymphocytes and
the 293 cell line
The day prior to infection, 293 cells were plated in
100-mm tissue culture dishes. The following day, the
media was removed and replaced with 10 ml of media
(mock infection) or media containing the B95.8 strain of
EBV. Infection was performed at 37°C in a tissue-culture
incubator. Twenty-four hours later, the mock- or virus-
containing media was removed and replaced with fresh
media. The cells were passed whenever they ap-
proached confluence. The peripheral blood lymphocytes
were resuspended in 1 ml of concentrated EBV stock
and infected for 2 h at 37°C with intermittent mixing. After
infection, cells were pelleted and resuspended in RPMI
1640 containing 10% fetal calf serum and supplemented
with antibiotics and glutamine, as previously described
(Woisetschlaeger et al., 1990, 1991).
Genomic DNA isolation and bisulfite-PCR
Genomic DNA was isolated from the EBV-infected
epithelial cell clones, as well as from the EBV-negative
Burkitt’s lymphoma cell line DG75, with the Blood and
Cell Culture DNA Maxi Kit (Qiagen, Valencia, CA), ac-
cording to the kit protocol. Genomic DNA (10–20 g) was
digested overnight with PstI (for Cp and Qp PCR) or
BamHI (for Wp PCR), ethanol-precipitated, resuspended
in water, and bisulfite-treated according to previously
described methods (Clark et al., 1994; McDonald and
Kay, 1997; Raizis et al., 1995), with a few minor changes.
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Five micrograms of DNA was denatured in 0.3 M NaOH
at 68oC for 15 min and incubated with 2.5 M sodium
metabisulfite (pH 5.0) and 0.5 mM hydroquinone for 3 to
4 h in the dark at 55°C. DNA was purified and desalted
with the GeneClean II kit (Bio 101, Inc., Vista, CA), de-
sulfonated in 0.3 M NaOH, and precipitated with ammo-
nium acetate, ethanol, and 1 g of carrier glycogen. By
this method, conversion of non-CpG cytosines into thy-
mines was 99.5 to 100% complete for all analyzed PCR
products.
Bisulfite-treated genomic DNA (0.3 to 1.5 g) was am-
plified using AmpliTaq Gold hot-start polymerase (Per-
kin–Elmer) in reaction buffer (per manufacturer’s proto-
col) containing 1.5 mMMgCl2 and primers specific for the
bottom strand of the EBV genome. The sequences of the
PCR primers used, and the assay conditions for each
primer set, were as follows. Cp PCR: 5 Cp PCR primer
(from genome coordinate bp 10,898), 5-CATACACCCTA-
AACCAACC; 3 Cp PCR primer (from genome coordinate
bp 11,385), 5-ATGAGGGTTTTGGGGGTTT. Reactions
were incubated at 95°C for 10 min followed by five cycles
of linear amplification with the 5 primer and 35 cycles of
amplification with both primers (94°C for 1 min, 63°C for
1 min, and 72°C for 2 min). Wp PCR: 5 Wp PCR primer
(from genome coordinate bp 13,918), 5-CCTATCAC-
CAAACCTACCA; 3 Wp PCR primer (from genome coor-
dinate bp 14,486), 5GGGGAAAAGTTAGAAATTGGGT.
PCR amplification reactions were incubated at 95°C for
10 min followed by five cycles of linear amplification with
the 5 primer and 35 cycles of amplification with both
primers (94°C for 1 min, 65°C for 1 min, and 72°C for 2
min). Qp PCR: 5 Qp PCR primer (from genome coordi-
nate bp 62,081), 5-CAAATACAAAAACTTA AATCTC; 3
Qp PCR primer (from genome coordinate bp 62,486),
5-GTTAAAATGTAAGGA TAGT ATG. PCR reactions were
incubated at 95°C for 10 min followed by five cycles of
linear amplification with the 5 primer and 35 cycles of
amplification with both primers (94°C for 1 min, 59°C for
1 min, and 72°C for 2 min). Bisulfite-treated DNA from
EBV-negative cells and water controls between samples
were included to ensure lack of contamination.
PCR cloning and sequencing
PCR products were cloned into the pGEM-T vector
(Promega, Madison, WI). Sequencing was performed
with a dye terminator cycle sequencing kit (PE Applied
Biosystems), using the pGEM-T vector primers SP6
and/or T7 (Promega), as well as the following sequence-
specific primers: 5CpBisSeq 1 (EBV genome coordinate
bp 10,898), 5-CATACACCCTAAACCAACC; 5CpBisSeq 2
(EBV genome coordinate bp 11,075), 5-CCAATA-
AAAAAACTCAAA; 5WpBisSeq 1 (EBV genome coordi-
nate bp 13,918), 5-CCTATCACCAAACCTACCA; 5Wp-
BisSeq 2 (EBV genome coordinate bp 14,115), 5-AAC-
CTAAACCTAAAACCCC; 5QpBisSeq (EBV genome
coordinate bp 62,181), 5-CTAACCTAACTAAAAATAAAAC.
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